GlobalReady Drug Development

Decades of deep clinical research management experience across Australia, New Zealand and North America

Our US CRO acquisition gives our biotech clients conducting their early phase studies in Australia and New Zealand a seamless journey into the US to continue their clinical development programs, retaining the same high-quality CRO, which reduces time and cost and delivers quality FDA-accepted data.

Rebates & FDA accepted data

In addition, the attractive 43.5% rebate on clinical spend in Australia, offers our clients the opportunity to utilize our North American operations expertise and team, whilst maintaining services in Australia to maximise their rebate potential.

This GlobalReady model is designed to extend biotechs’ investments so they can achieve greater clinical development milestones with reduced spend, all with the assurance of FDA accepted data.

Early to late Phase  Success

We often point to the fact that there are currently more than 280 Phase III global trials that have conducted their Phase I study in Australia, which again demonstrates Australian data acceptability with the FDA and other major regulatory authorities.

Investing in our US operations

We will be making significant investments in our US operations including growing the team to more than 120 people and leveraging their deep industry experience across a broad range of therapeutic areas, in particular oncology.

The advanced technology, systems and processes that clients expect at Avance Clinical will also be rolled out and immediately available through our North American operations.

The North America Avance Clinical leadership team

Request a Proposal or Talk to our Team  CONTACT US

Learn more about GlobalReady

Streamlined early to late phase trials in Australia, New Zealand and North America

Clinical Monitoring Management

All Avance Clinical trials are monitored in accordance with Australian, New Zealand and US regulatory requirements and ICH GCP.

Learn More

ClinicReady - get into clinic faster

With ClinicReady, Avance Clinical’s team can act as a surrogate drug development department for start-up companies.

Learn More

Data Management

Avance Clinical data management team have gained a world-class reputation for accuracy, precision, and quality of their biostatistics and pharmacokinetic (PK) analysis.

Learn More

eclinical

The Avance Clinical team works with eClinical leaders such as Medrio, Medidata and Oracle to offer regulatory compliant and patient-centric tools for rapid start-up and continual data flow.

Learn More

Project Management

Avance Clinical provides each clinical research trial with a dedicated Project Manager to ensure that milestones are reached, timelines are met and that our clients receive effective communication and ongoing status reports.

Learn More

Quality Assurance

Data quality is at the heart of everything at Avance Clinical. Delivered by our highly experienced staff we support our clients with their clinical trial audit to achieve their quality objectives for their clinical research trials.

Learn More

Safety and Pharmacovigilance

Clinical trials safety monitoring and reporting is vital to ensure participant safety, data integrity and regulatory compliance.

Learn More

Medical Writing

The Avance Clinical biostatistics and pharmacokinetics experts provide specialist guidance for your clinical research trial design and analysis.

Learn More

Full Service CRO

Avance Clinical is the leading full-service CRO for international biotechs conducting early to late Phase clinical trials.

The latest technology for data compliance

The company has focussed on state-of-the-art technology and systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of the technology partners.

Avance Clinical offers globally accepted data from an established clinical trial ecosystem, that includes world-class PIs and Sites that are able to rapidly access specialized patient groups.

The Australian Government R&D grant means up to 43.5% rebate on clinical trial spend
Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks
Globally accepted data
No IND required for clinical trials

Request a Proposal or Talk to our Team  CONTACT US

Talk to Avance Clinical about your next study

More benefits

Almost half clinical costs

The Government R&D grant means up to 43.5% rebate on clinical trial spend

Rapid Start-up

Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks

Start-up time

Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks

No IND

No IND required for clinical trials

GMP material

Full GMP material is not mandated for Phase I clinical trials

Gene-therapy accreditation

Avance Clinical is an accredited gene-therapy CRO

Seasonal studies

Northern hemisphere Sponsors can conduct their studies year-round by taking advantage of Australia and New Zealand's counter-flu and allergy seasons

FDA and global regulatory data compliance

Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with a long track record in FDA compliant research

Rebate

The Government R&D grant means up to 43.5% rebate on clinical trial spend

Start-up time

Site Initiation Visit (SIV) and Study Start achieved in 5 – 6 weeks

Capabilities

Full service CRO in Australia and New Zealand

195
Studies in the past 5 years
250
Experienced Team Members
10,000
Participants past 5 years
24
Years of of CRO experience

“Avance Clinical’s clients are international biotech companies primarily from the United States, United Kingdom, Japan, China, South Korea, Taiwan, France, and Germany. These clients are seeking a premium CRO with the same experience and advanced technology platforms offered by the major global CROs, but with an agile and customer focused approach to clinical management in Australia and New Zealand.”

Supriya Lala KunduBest Practices Research Analyst, Frost & Sullivan

Ready To Partner with Us?

Contact Us